IMMUNITYBIO, INC. (IBRX) Revenue 2016–2025
IMMUNITYBIO, INC. (IBRX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$113.3MFY2025 · since FY2016: $44,000 → $113.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $113.3M | +668.3% |
| FY2024 | $14.7M | +2270.6% |
| FY2023 | $622,000 | +159.2% |
| FY2022 | $240,000 | -74.3% |
| FY2021 | $934,000 | +54.4% |
| FY2020 | $605,000 | -72.5% |
| FY2019 | $2.2M | +4585.1% |
| FY2018 | $47,000 | +4.4% |
| FY2017 | $45,000 | +2.3% |
| FY2016 | $44,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice